The World Health Organization announced on 16 November 2026 that it has validated Eritrea's elimination of trachoma as a public health problem. Eritrea is the 34th country in the world, and the 11th in WHO's African Region, to reach that point against the bacterial eye infection, which is the leading infectious cause of blindness.

The decision is more than a ministry declaring victory. According to WHO, validation comes only after an independent dossier review group appointed by the organisation checks a country's evidence, confirms that agreed epidemiological thresholds have been met, and is satisfied that systems exist to find and treat future cases.

Two decades of surveys, treatment and sanitation

Trachoma spreads through contact with eye and nose discharge, and it thrives where water and sanitation are scarce. Repeated infections scar the inside of the eyelid until the lashes turn inward and scrape the eye, a painful condition called trichiasis that can end in blindness.

Eritrea set up its National Blindness Prevention Program in 2006, and baseline surveys ran in different parts of the country between 2006 and 2020. WHO says all 58 sub-zobas, the country's second-level administrative areas, were surveyed, and the recommended SAFE approach was applied wherever the disease was found: surgery for trichiasis, antibiotics, face washing, and better water and sanitation.

The International Trachoma Initiative, which manages Pfizer's donation of the antibiotic azithromycin, says Eritrea received 3,087,120 treatments between 2009 and 2021, with mass drug distribution starting in 2011. Surveys between 2014 and 2022 found that active infection among children aged one to nine had fallen below WHO's 5% elimination threshold in all 25 treated districts. When prevalence rose again in Adi Quala after early treatment rounds, the programme resumed mass treatment there, and a 2024 survey showed it back below 5%. ITI also reports 34 trichiasis surgery centres, more than 1,000 trained case finders, and 93% of the country's 2,830 villages certified free of open defecation by July 2025.

The Fred Hollows Foundation, a long-standing partner of the programme, describes community health agents making house-to-house visits, mobile surgical teams reaching remote areas, and schools promoting face and hand washing. WHO credits a community-led sanitation approach that achieved results with limited external funding.

What validation does not mean

Elimination "as a public health problem" is not the same as eradication. It means infection and trichiasis have dropped below defined thresholds, not that no one in Eritrea will ever contract trachoma again. WHO and ESPEN, its African neglected-disease programme, both stress the need for continued surveillance, and Eritrea plans periodic surveys and ongoing surgery to prevent a return.

Most of the programme figures above come from organisations that took part in the work, including WHO, ITI and the Fred Hollows Foundation, so they are attributed accordingly. The validation itself rests on the independent dossier review.

The wider picture still has a long way to go. WHO says that as of March 2026, 92 million people lived in areas where trachoma remained endemic, and the disease was still a public health problem in at least part of 29 countries. With this validation, Eritrea becomes the 66th country to have eliminated at least one neglected tropical disease, according to WHO.